Avinger sees best day in 10 months after expanded approval for surgery device

Avinger

17/11/2021 15:44

** Medical device maker's shares  AVGR.O  jump as much as
40.6% to 96 cents; stock one of top three gainers across
exchanges and set for best day in over 10 months
    ** Co receives FDA clearance to expand the use of its
Pantheris system to treat in-stent restenosis (ISR) in lower
extremity arteries  urn:newsml:reuters.com:*:nACS16G98a
    ** ISR is a condition in which a part of a blocked artery
that was opened up with a stent in surgery becomes narrow again
    ** AVGR's Pantheris was approved in 2015 for atherectomy, a
treatment in which plaque build-up is cut from a blood vessel
before it can eventually lead to a heart attack
    ** About 24 mln shares change hands, about 25x 25-DMA
    ** Stock has risen 57% this year up to Tuesday; Wednesday's
moves bring it up to 90%

 (Reporting by Ruhi Soni in Bengaluru;)
 ((Ruhi.Soni@thomsonreuters.com; Twitter: https://twitter.com/ruhithere;))